| Accession |
PRJCA005133 |
| Title |
Study on Severe New Crown Pneumonia Patients with Artificial Liver Treatment |
| Relevance |
Medical |
| Data types |
Assembly
clinical information
|
| Organisms |
Homo
|
| Description |
Artificial liver system can clear inflammatory mediators to block the cytokine storm, preventing severe cases of COVID-19 from progressing to critically severe type, thus remarkably reducing the fatality rate of severe and critically severe patients. Furthermore, it works more effectively on severe patients in the early stage of cytokine storm and reduces the mortality rate more than 30 % .Early and accurate prediction of which NCP patients will develop into severe and critical conditions, early hierarchical management of these patients, and targeted treatment measures in advance are the keys to reducing mortality, reducing medical burden and maintaining the fight against the epidemic. Screening antiviral drugs with high efficacy is the key to successful treatment. |
| Sample scope |
clinical information |
| Release date |
2021-09-01 |
| Publication |
| PubMed ID |
Article title |
Journal name |
DOI |
Year |
|
|
Effect of artificial liver blood purification treatment on the survival of critical ill COVID-19 patients
|
Artificial organs
|
10.111/aor.13884
|
2021
|
|
|
Expert consensus on the application of artificial liver blood purification system in the treatment of severe and critical COVID-19
|
Chin J Clin Infect Dis
|
10.3760/cma.j.issn.1674-2397.2020.01.001
|
2020
|
|
|
Risk factors for fatal outcome in patients with severe COVID-19: an analysis of 107 cases in Wuhan
|
Chin J Clin Infect Dis
|
10.3760/cma.j.issn.1674-2397.2020.04.002
|
2020
|
|
|
Clinical analysis of 80 death cases with corona virus disease 2019
|
Chin J Infect Dis
|
10.3760/cma.j.cn311365-20200304-00206
|
2021
|
|
|
| Grants |
| Agency |
program |
Grant ID |
Grant title |
| Ministry of Science and Technology of the People's Republic of China (MOST)
|
National Key Technologies R&D Program
|
2020YFC0844300
|
Study on Severe New Crown Pneumonia Patients with Artificial Liver Treatment
|
|
|
| Submitter |
Mengfei
Zhu (13706513269@126.com)
|
| Organization |
shulang(hangzhou) hospital |
| Submission date |
2021-05-17 |
